- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05221853
Real-time MRI for Evaluating Cardiac Volumetry
Comparison of Standard Breath-hold Cardiac MRI With a Faster, Free-breathing Scan
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a single-centre prospective study involving up to 570 patients with known or suspected cardiac disease referred for routine clinical cardiovascular magnetic resonance (CMR) assessment at Glenfield General Hospital, Leicester. In addition to standard multi-breath-hold steady-state free precession (SSFP) imaging (undertaken as part of the routine scan), each patient will also undergo additional imaging with a non-breath-hold multi-slice real-time cine sequence.
The primary outcome is the assessment of cardiac volumetry and function (end-diastolic volume, end-systolic volume, stroke volume, ejection fraction and myocardial mass) as measured by (1) the standard multi-breath-hold SSFP technique and (2) the non-breath-hold multi-slice real-time cine sequence. Secondary outcome measures will be (1) the time required for each scan, and (2) image quality for each scan. An additional secondary outcome will be to compare indexed cardiac volumes with those indexed according to measured body-surface area.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jayanth Arnold, BMBCh
- Phone Number: 01162583038
- Email: jra14@le.ac.uk
Study Contact Backup
- Name: Mohamed Elshibly
- Phone Number: 01162583038
- Email: mmme1@le.ac.uk
Study Locations
-
-
Leics
-
Leicester, Leics, United Kingdom, LE3 9QP
- Recruiting
- Glenfield Hospital
-
Contact:
- Jayanth Arnold
- Phone Number: 01162583038
- Email: jra14@le.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged ≥ 18 years
- Referred for routine CMR imaging
- Willing and able to give informed consent
- Willing and able to comply with the requirements of the study
- Able to understand written English
Exclusion Criteria:
- Severe claustrophobia
- Absolute contraindications to CMR (those with CMR conditional or safe devices will be eligible for inclusion)
- Unable to provide informed consent
- Participants unable to understand written English
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac volumetric assessment 1
Time Frame: 1 day
|
Left ventricular ejection fraction
|
1 day
|
Cardiac volumetric assessment 2
Time Frame: 1 day
|
Left ventricular end-diastolic volume
|
1 day
|
Cardiac volumetric assessment 3
Time Frame: 1 day
|
Left ventricular myocardial mass
|
1 day
|
Cardiac volumetric assessment 4
Time Frame: 1 day
|
Right ventricular ejection fraction
|
1 day
|
Cardiac volumetric assessment 5
Time Frame: 1 day
|
Right ventricular end-diastolic volume
|
1 day
|
Cardiac strain assessment 1
Time Frame: 1 day
|
Left ventricular global longitudinal strain
|
1 day
|
Cardiac strain assessment 2
Time Frame: 1 day
|
Left ventricular global circumferential strain
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time
Time Frame: 1 day
|
the time required for each scan under evaluation (real-time Cine and standard Cine)
|
1 day
|
Image quality assessment
Time Frame: 1 day
|
Image quality of each scan component, assessed visually on a 4-point score - excellent (3), good (2), moderate (1) and poor (0).
|
1 day
|
Body-surface area
Time Frame: 1 day
|
planimetered body-surface area
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jayanth Arnold, University of Leicester
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0768
- 270285 (Other Identifier: Health Research Authority)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Left Ventricle Abnormality
-
University of GroningenUnknownDouble Inlet Left Ventricle
-
AstraZenecaCompletedLeft Ventricle FunctionSweden
-
Nationwide Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsRecruitingHeart Diseases | Cardiovascular Diseases | Heart Defects, Congenital | Cardiovascular Abnormalities | HLH - Hypoplastic Left Heart Syndrome | DORV | DILV - Double Inlet Left Ventricle | Mitral Atresia | Tricuspid Atresia | Unbalanced AV Canal | Single-ventricleUnited States
-
Aga Khan University Hospital, PakistanCompletedLeft Ventricle Non-compaction Cardiomyopathy
-
Okayama UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanCompletedHypoplastic Left Heart Syndrome | Single Right Ventricle | Single Left VentricleJapan
-
University of California, San FranciscoTerminatedTricuspid Atresia | Hypoplastic Left Heart Syndrome | Double Inlet Left Ventricle | Fontan ProcedureUnited States
-
Medical University of SilesiaPolpharma Pharmaceutical CompanyTerminatedFirst Time Dual Chamber Pacemaker ImplantationPoland
-
University of Colorado, DenverRecruitingSingle-ventricle | Pulmonary Vascular Resistance Abnormality | Metabolomics | Superior Cavo-Pulmonary Anastomosis | EndothelinUnited States
-
Novartis PharmaceuticalsCompletedHypertension | Left Ventricle HypertrophySpain
-
BioVentrixAvailableHeart Failure | Left Ventricle RemodelingUnited States
Clinical Trials on cardiovascular magnetic resonance
-
National Heart Centre SingaporeUnknownHypertension | Ischemic Heart Disease | Cardiomyopathy, Dilated | Cardiomyopathy, Hypertrophic | Left Ventricular HypertrophySingapore
-
Cardiocentro TicinoRecruitingNon-ST Elevation Myocardial Infarction (NSTEMI)Switzerland
-
Dipan ShahRecruiting
-
University Hospital, Basel, SwitzerlandTerminatedCoronary Artery Disease | Lupus Erythematosus, Systemic | Myocardial DiseaseSwitzerland
-
University of LeicesterUniversity Hospitals, LeicesterCompleted
-
Medical University InnsbruckRecruitingAcute ST-Elevation Myocardial InfarctionAustria
-
Sheffield Teaching Hospitals NHS Foundation TrustWithdrawn
-
Society for Cardiovascular Magnetic ResonanceUnknownCardiovascular Diseases
-
Boston Children's HospitalCompleted
-
National Heart Centre SingaporeCompletedHeart FailureSingapore